Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

SRP3318

Sigma-Aldrich

C1 Inhibitor Peptide

≥95% (HPLC), lyophilized powder, human recombinant, expressed in CHO cells

Synonyme(s) :

C1inh, Plasma protease C1 inhibitor, Serpin G1

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
12352202
Nomenclature NACRES :
NA.32

product name

C1 Inhibitor human, recombinant, expressed in CHO cells, ≥95% (SDS-PAGE), ≥95% (HPLC)

Source biologique

human

Produit recombinant

expressed in CHO cells

Pureté

≥95% (HPLC)
≥95% (SDS-PAGE)

Forme

lyophilized

Puissance

≤2.6 nM IC50

Poids mol.

52.8 kDa

Conditionnement

pkg of 200 μg

Impuretés

endotoxin, tested

Numéro d'accès UniProt

Conditions d'expédition

wet ice

Température de stockage

−20°C

Informations sur le gène

human ... SERPING1(710)

Description générale

Plasma protease C1 inhibitor is a member of the serpin family of structurally related proteins. Recombinant Human C1 inhibitor is a highly glycosylated glycoprotein containing 478 amino acid residues (52.8kDa), corresponding to amino acids 23-500 of the C1 inhibitor precursor, and is fully functional in its ability to inhibit the C1 complex. Glycosylated C1 inhibitor migrates at an apparent molecular weight of approximately 80-90kDa by SDS PAGE analysis under reducing conditions.

Actions biochimiques/physiologiques

Plasma protease C1 inhibitor is the primary regulator of the immune complement system. C1 inhibitor is a protease inhibitor that functions to inhibit the complement system in order to prevent over-activation or spontaneous activation. Inhibition is achieved by binding to and irreversibly inhibiting the C1r and C1s proteases of the C1 complex, which has the effect of shutting down all subsequent downstream events in the complement activation cascade. C1 inhibitor can also inhibit various other proteases, including Kallikrein, Factor XIa, and Factor XIIa. Deficiencies in C1 inhibitor are the primary cause of hereditary angioedema (HAE, hereditary angioneurotic edema), a disease characterized by edema in the respiratory and gastrointestinal tracts. In certain clinical situations, the direct administration of C1 inhibitor can be used to treat HAE and certain other conditions.

Forme physique

Lyophilized from 10mM Sodium Phosphate, pH 7.5.

Reconstitution

Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at -20°C to -80°C.

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

C1-inhibitor deficiency and angioedema.
Carugati A
Molecular Immunology, 38(2-3), 161-173 (2001)
C1 inhibitor.
A E Davis et al.
Methods in enzymology, 223, 97-120 (1993-01-01)
Sayani Mukherjee et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 40(41), 7965-7979 (2020-09-06)
Microglia, a type of CNS immune cell, have been shown to contribute to ethanol-activated neuronal death of the stress regulatory proopiomelanocortin (POMC) neuron-producing β-endorphin peptides in the hypothalamus in a postnatal rat model of fetal alcohol spectrum disorders. We determined
C1 Esterase Inhibitor (Human)
P & T : A Peer-Reviewed Journal for Formulary Management, 35, 2-3 (2010)
In vivo biosynthesis of endogenous and of human C1 inhibitor in transgenic mice: tissue distribution and colocalization of their expression.
Vinci G
Journal of Immunology, 169(10), 5948-5954 (2002)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique